Pädiatrische Rheumatologie
2009
Albers HM, Wessels JA, van der Straaten RJ, Brinkman DM, Suijlekom-Smit LW, Kamphuis SS, Girschick HJ, Wouters C, Schilham MW, le Cessie S, Huizinga TW, Ten Cate R, Guchelaar HJ (2009): Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
Arthritis Rheum. 61(1):46-51
Albers HM, Kurreeman FA, Stoeken-Rijsbergen G, Brinkman DM, Kamphuis SS, van Rossum MA, Girschick HJ, Wouters C, Saurenmann RK, Hoppenrejis E, Slagboom P, Houwing-Duistermaat JJ, Verdujin W, Huizinga TW, Ten Cate R, Toes RE, Schilham MW (2009): Association of the autoimmunity locus 4q27 with juvenile idiopathic arthitis.
Arthritis Rheum. 60(3):901-4
Beck C, Morbach H, Richl P, Stenzel M, Girschick HJ (2009): How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint disease?
Rheumatol Int. 29(3):229-38
Beck C, Beer M, Morbach H, Raab P, Girschick HJ (2009): Differenzialdiagnose von Knochenschmerzen im Kindes- und Jugendalter.
Pädiat. Prax. 74:113-18.
Beck C, Morbach H, Stenzel M, Schneider P, Collmann H, Girschick G, Girschick HJ (2009): Hypophosphatasia.
Klin Padiatr. 221(4):219-26
Beck C, Morbach H, Stenzel M, Collmann H, Schneider P, Girschick HJ. (2009): Hypophosphatasia – recent advances in diagnosis and treatment.
The Open Bone Journal 1:8-15.
Beck C, Stenzel M, Schneider P, Girschick HJ. (2009): Hypophosphatasie – aktuelle Diagnostik und Therapie.
J Miner Stoffwechs 16 (3):122-127.
Collmann H, Mornet E, Gattenlöhner S, Beck C, Girschick H. (2009): Neurosurgical aspects of childhood hypophosphatasia.
Child Nerv Syst 25:217-23.
Von Chamier G, Holl-Wieden A, Stenzel M, Raab P, Darge K, Girschick HJ, Beer M (2009): Pitfalls in diagnostics of hip pain: osteoid osteoma and osteoblastoma.
Rheumatol Int. May 15 (epub ahead of print)
Girschick HJ, Morbach H, Tappe D (2009): Treatment of Lyme borreliosis.
Arthritis Research & Therapy Dec. 17 (epub ahead of print)
Horneff G, Ebert A, Fitter S, Minden K, Foeldvari I, Kümmerle-Deschner J, Thon A, Girschick HJ, Weller F, Huppertz HI (2009): Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.
Rheumatology 48(8):916-9
Humrich JY, Morbach H, Undeutsch R, Enhard P, Rosenberger S, Weigert O, Kloke L, Heimann J, Gaber T, Brandenburg S, Scheffold A, Huehn J, Radbruch A, Burmester GR, Riemekasten G (2009): Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc Natl Acad Sci USA Dec 14 (epub ahead of print)
Jakob F, Ebert R, Seefried L, Beck Ch, Girschick H. (2009): Laboruntersuchungen bei metabolischen Osteopathien.
Osteologie 18 (1): 16-23.
Martini G, Ramanan AV, Falcini F, Girschick H, Goldsmith DP, Zulian F (2009): Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.
Rheumatology. 48(11):1410-3
Morbach H, Richl P, Stojanov S, Lohse P, Girschick HJ (2009): Tumor necrosis factor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept traetment.
Rheumatol Int. Apr. 19 (epub ahead of print)
Morbach H, Dick A, Beck C, Stenzel M, Müller-Hermelink HK, Raab P, Girschick HJ (2009): Association of chronic non-bacterial osteomyelitis with Crohn`s disease but not with CARD15 gene variants.
Rheumatol Int. Jul 5. (epub ahead of print)
Morbach H, Girschick HJ (2009): Do B cells play a role in the pathogenesis of juvenile idiopathic arthritis.
Autoimmunity. 42(4): 373-5
Wiegering V, Morbach H, Dick A, Girschick HJ (2009): Crohn`s disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature.
Rheumatol Int. Jun. 9 (epub ahead of print)
2008
Albers HM, Kurreeman FAS, Houwing-Duistermaat JJ, Brinkmann DMC, Kamphuis SSM, Girschick HJ, Wouters C, Van Rossum MAJ, Verduyn W, Toes REM, Huizinga TWJ, Schilham MW, ten Cate R (2008): The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis.
Ann Rheum Dis 67:1578-80
Albers HM, Wessels JA, von der Straaten RJ,Brinkman DM, Suijlekom-Smit LW,Kamphuis SS, Girschick HJ, Wouters C, Schilham MW, le Cessie S, Huizinga TW, Ten Cate R, Guchelaar HJ (2008): Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
Arthritis Rheum 61:46-51
Beer M, Stenzel M, Girschick HJ, Schlegel PG, Darge K (2008): Whole-body MR imaging in children with suspected osteonecrosis after intensive chemotherapy: preliminary results.
Rofo 180:238-45
Collmann H, Mornet E, Gattenlöhner S, Beck C, Girschick HJ (2008): Neurosurgical aspects of childhood hypophosphatasia.
Childs Nervous System 25:217-23
Girschick HJ (2008): Scleroderma in childhood and adolescence: New aspects on classification, etiology and therapy.
Z Rheumatol 67:128-36
Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S, Doria A (2008): Bacterial triggers of autoimmune rheumatic diseases.
Clin Exp Rheumatol 26:12-7
Girschick HJ, Morbach H (2008): Konventionelle Therapie des systemischen Lupus im Kindes-und Erwachsenenalter.
Aktuelle Rheumatologie 33:160-5
Girschick HJ, Zimmer C, Stenzel M, Morbach H (2008): Chronische nicht-bakterielle Osteomyelitis im Kindes- und Jugendalter.
Ärzteblatt Thüringen 2:82-5
Gottfried E, Kunz-Schughart LA, Weber A, Rehli M, Peuker A, Müller A, Kastenberger M, Brockhoff G, Andreesen R, Kreutz M (2008): Expression of CD68 in non-myeloid cell types.
Scand J Immunol 67, 453-63
Holl-Wieden A, Beer M, Marx A, Bonfig R, Tappe D, Girschick HJ (2008): Infection of an urachal cyst during etanercept therapy in juvenile idiopathic arthritis.
Rheumatol Int. 28:819-22
Morbach H, Richl P, Faber C, Singh SK, Girschick HJ (2008): The kappa immunoglobulin light chain repertoire of peripheral blood B cells in patient with juvenile rheumatoid arthritis.
Mol Immunol 14:3840-6
Morbach H, Stenzel M, Girschick HJ (2008): Bisphosphonate treatment in chronic non-bacterial osteomyelitis.
Nat Clin Pract Rheumatol 4:570-1
Ridder-Schröter R, Marx A, Beer M, Kreth HW, Girschick HJ (2008): Absess-forming lymphadenitis and osteomyelitis in children with bartonella henselae infection.
J Med Microbiol 57:519-24
Singh SK, Bhadra MP, Girschick HJ, Bhadra U (2008) MicroRNAs: Micro in size but macro in function.
2007
Eltermann T, Beer M, Girschick HJ (2007): Magnetic resonance imaging in child abuse.
J Child Neurol 22: 170-175
Girschick HJ: Enthesitis assoziierte Arthritis.
In: Wagner N, Dannecker G (2007): Pädiatrische Rheumatologie, Springer Verlag, Berlin
Girschick HJ, Huppertz HI: Reaktive Arthritis.
In: Wagner N, Dannecker G (2007): Pädiatrische Rheumatologie, Springer Verlag, Berlin
Girschick HJ, Huppertz HI, Latsch K: Lyme Arthritis.
In: Wagner N, Dannecker G (2007): Pädiatrische Rheumatologie, Springer Verlag, Berlin
Girschick HJ: Nichtbakterielle Osteomyelitis.
In: Wagner N, Dannecker G (2007): Pädiatrische Rheumatologie, Springer Verlag, Berlin
Girschick HJ: Sklerodermie.
In: Lentze/Schaub/Schulte/Spranger (2007): Pädiatrie, Springer Verlag, Berlin
Girschick HJ, Haubitz I, Hiort O, Schneider P (2007): Long-term follow-up of bone mineral density in childhood hypophosphatasia.
Joint Bone Spine 74: 263-269
Girschick HJ, Haubitz I, Hiort O, Schneider P (2007): Évolution au long cours de la densité minérale osseuse dans l’hypophosphatasie juvénile.
Revue du Rhumatisme 74: 479-485
Girschick HJ, Mornet E, Beer M, Warmuth-Metz M, Schneider P (2007): Chronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancy.
BioMedCentral Pediatrics 7: 3
Girschick HJ, Zimmer C, Klaus G, Darge, K, Dick, A, Morbach H (2007): Chronic recurrent multifocal osteomyelitis – What is it and how should we treat it?
Nat Clin Pract Rheumatol 3 (12): 733-738
Holl-Wieden A, Surbaum S, Girschick HJ (2007): Seronegative Lyme Arthritis.
Int J Rheumatol 27: 1091-1093
Latsch K, Girschick HJ, Abele-Horn M (2007): Stevens-Johnson Syndrome presenting without skin lesions.
J Med Microbiol 2007;56: 1696-1699
Reutter G, Girschick HJ (2007): Pachydermoperiostosis als Differentialdiagnose in der Kinderrheumatologie.
Monatsschr Kinderheilkd 156: 8-10
Roth J, Bechthold S, Borte G, Dressler F, Girschick HJ, Borte M (2007): Osteoporosis in JIA – a practical approach to diagnosis and therapy.
Eur J Pediatr 166: 775-784
Roth J, Bechthold S, Borte G, Dressler F, Girschick HJ, Borte M (2007): Diagnose, Prophylaxe und Therapie der Osteoporose bei juveniler idiopathischer Arthritis.
Zeitschr Rheumatol 66 (5): 434-440
Schäd SG, Kraus A, Haubitz I, Trcka J, Hamm H, Girschick HJ (2007): Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis.
Arthritis Res Ther 9: 1 R10
Weissbrich B, Suss-Frohlich Y, Girschick HJ (2007): Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
Arthritis Res Ther 9 (4): R82
2006
Kreth HW, Hoeger PH; The Members of the VZV-AD study group (2006): Safety, reactogenicity, and immunogenicity of live attenuated varicella vaccine in children between 1 and 9 years of age with atopic dermatitis. Eur J Pediatr. 165:677-83
Weissbrich B, Neske F, Schubert J, Tollmann F, Blath K, Blessing K, Kreth HW (2006): Frequent detection of bocavirus DNA in German children with respiratory tract infections. BMC Infect Dis. 11:109
Girschick HJ, Schneider P, Haubitz I, Hiort O, Collmann H, Beer M, Shin YS, Seyberth HW (2006): Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia. Orphanet Journal of Rare Diseases 1:24
Holl-Wieden A, Klink T, Klink J, Warmuth-Metz M, Girschick HJ (2006): Linear scleroderma “en coup de sabre” associated with cerebral and ocular vasculitis. Scandinavian Journal of Rheumatology 35:402-404
Klotz P, Tappe D, Abele-Horn M, Warmuth-Metz M, Sörensen N, Speer CP, Girschick HJ (2006): Cerebral Mass in a 13-Year-Old Girl Following Long-Term Sojourn in the Tropics. Journal of Medical Microbiology 55:345-347
Faber C, Morbach H, Singh SK, Girschick HJ (2006): Differential expression patterns of Recombination Activating Genes in individual mature B cells in Juvenile Idiopathic Arthritis. Annals of Rheumatic Diseases 65: 1351-1356
Jansson A, Borte M, Böschow G, Dressler F, Grübner I, Kekow M, Palm-Beden K, Girschick HJ (2006): Nicht bakterielle Osteitis des Kindes- und Erwachsenenalters Monatsschrift f. Kinderheilkunde 154: 831-833
Valenza G, Burgemeister S, Hermann Girschick, Schoen C, Veihelmann S, Moter A, Haban V, Vogel U, Schlagenhauf U (2006): Analysis of the periodontal microbiota in childhood-type hypophosphatasia. International Journal of Medical Microbiology epublished
Roth J, Bechthold S, Borte G, Dressler F, Girschick HJ, Borte M (2006): Osteoporose bei juveniler idiopathischer Arthritis. Monatsschrift f. Kinderheilkunde, 154:456-464
Wahn V, Schwarz K, Girschick HJ, Friedrich A (2006): Disorders of the T cell receptor and primary signal transduction. Allergologie 29:71-75
Martini G, Foeldvari I, Girschick H, Zulian F (2006): Systemic sclerosis in childhood: Clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 54:3971-3978
Singh SK, Girschick HJ (2006): Toll like receptors in Borrelia burgdorferi induced inflammation. Clinical Microbiology and Infection 12: 705-717
Girschick HJ (2006): Osteomyelitis in childhood. Current Medical literature, Pediatrics 19: 1-7
Girschick HJ, Haubitz I, Hiort O, Schneider P (2006): Long-term follow-up of bone mineral density in childhood hypophosphatasia. Joint Bone Spine in print
Latsch K, Tappe D, Warmuth-Metz M, Hebestreit H. (2006): Central nervous system borreliosis mimicking a pontine tumour. J Med Microbiol. 55(Pt 11):1597-9
2005
Singh SK, Morbach H, Nanki T, Wirsing A, Girschick HJ (2005): Differential expression of chemokines in synovial cells infected with different Borrelia burgdorferi isolates. Clinical and Experimental Rheumatology, in press
Girschick HJ, Raab P, Surbaum S, Trusen A, Kirschner S, Schneider P, Papdopoulos T, Müller-Hermelink HK, Lipsky P (2005): Chronic recurrent multifocal osteomyelitis in children: long term follow-up and treatment of relapses. Annals of Rheumatic Diseases 64:279-285
Girschick H, Foeldvari I (2005): Systemische Sklerose, progressiv systemische Sklerodermie: In Leitlinien Kinderheilkunde und Jugendmedizin, hrsg. von K. v Schnakenburg. Urban und Fischer Verlag, München H7:8-11
Kunzmann S, Warmuth A, Girschick HJ (2005): Cerebral demyelination in association with TNF-inhibition therapy in a 5-year-old girl with aseptic meningitis as first symptom of Still`s disease. Scandinavian Journal of Rheumatology 34:76-78
Margarida Souto-Carneiro M, Sims GP, Girschick H, Lee J, Lipsky PE (2005): Developmental Changes in the Human Heavy Chain CDR3. The Journal of Immunology 175: 7425–7436
Girschick H, Jannson A (2005): Chronisch nicht-bakterielle Osteomyelitis. In Leitlinien Kinderheilkunde und Jugendmedizin, hrsg. von K. v Schnakenburg; Urban und Fischer Verlag, München. H5:1-4
Girschick H, Lehmann HW, Niehues T (2005): Coxitis fugax und virale Arthritiden. In Leitlinien Kinderheilkunde und Jugendmedizin, hrsg. von K. v Schnakenburg; Urban und Fischer Verlag, München. H6:1-4
Dressler F, Hobusch D, Girschick HJ, Huppertz HI (2005): Lyme-Arthritis. In Leitlinien Kinderheilkunde und Jugendmedizin, hrsg. von K. v Schnakenburg; Urban und Fischer Verlag, München. H6:4-6
Girschick H, Lehmann HW, Niehues T (2005): Systemischer Lupus erythematodes.In Leitlinien Kinderheilkunde und Jugendmedizin, hrsg. von K. v Schnakenburg; Urban und Fischer Verlag, München. H7:1-4
2004
Dressler F, Girschick HJ, Huppertz HI, Lahdenne P (2004): Pediatric Rheumatology European Society clinical guidelines Lyme arthritis. Pediatric Rheumatology Online Journal, July/August
Horneff G, Schmeling H, Biedermann T, Foeldvari I, Ganser G, Girschick HJ, Hospach T, Huppertz HI, Keitzer R, Küster RM, Michels H, Moebius D, Rogalski B, Thon A (2004): The German Etanercept Registry for Treatment of Juvenile Idiopathic Arthritis. Annals of Rheumatic Diseases 63:1638-44
Girschick HJ (2004): Rheuma bei Kindern. Blick 2:44-46
Girschick HJ, Sulimma F, Girschick G, Trusen A, Waller W (2004): Idiopathische orbitale Myositis: Erstbeschreibung der Therapie mit dem NSAID Naproxen. Monatsschrift für Kinderheilkunde 152:307-311
Singh SK, Girschick HJ (2004): Lyme borreliosis: from infection to autoimmunity. Clinical Microbiology and Infection 10:598-614
Singh SK, Girschick HJ (2004): Molecular survival strategies of the Lyme disease spirochete Borrelia burgdorferi. The Lancet Infectious Diseases 4:575-583
Singh SK, Morbach H, Nanki T, Faber C, Baar V, Wirsing A, Girschick HJ (2004): Differential expression of matrix metalloproteinases and cyclooxygenases in synovial cells infected with different Borrelia burgdorferi isolates. Inflammation research 53:689-696
2003
Singh S, Girschick HJ (2003): Tick-host interactions and their immunological implications in tick borne diseases. Curr Sci 85:1284-1298
Girschick HJ (2003): Schützen Infektionen vor Autoimmunität oder lösen sie Autoimmunerkrankungen aus? Med Report 28: 12
Grammer AC, Slota R, Fischer R, Gur H, Girschick H, Yarboro C, Illei G, and Lipsky PE (2003): Evidence of abnormal GC reactions in active SLE: assessment by in vivo blockade of CD154-CD40 interactions. Journal of Clinical Investigation 112:1506-1520
Böhler T, Girschick HJ, Horneff G (2003): Neutropenie. Allergol 12:533-538
2002
Nanan R., Heinrich D., Frosch M., Kreth H.W. (2002) Acute and long-term effects of booster immunization and frequencies of antigen-specific memory-B lymphocytes. Vaccine 20:498 - 504;
Eichner M., Diebner H.H., Schubert C., Kreth H.W., Dietz K. (2002) Estimation of the time dependent vaccine efficacy from a measles epidemic. Statist. Med. 21: 2355 - 2368;
Brunner C., H.W. Kreth, H.D. Ochs, V. Schuster (2002) Unimpaired activation of c-Jun NH2-Terminal kinase (JNK)1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia. J. Clin. Immunol. 22:244 - 251;
Brunner C., A. Avots, H.W. Kreth, E. Serfling, V. Schuster (2002). Bruton´s tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes. Immunobiol. 206:432 - 440;
Nanan R., P. Ströbel, J.-P. Haas, A. Marx, H.W. Kreth (2002) Autoimmune lymphoproliferative syndrome associated with severe humoral immunodeficiency and monoclonal gammopathy. Ann. Hematol. 81:332 - 335
Girschick HJ, Grammer AC, Nanki T, Lipsky PE (2002): RAG1 and RAG2 expression in systemic lupus erythematosus. Arthr Rheumat 46:1255-1263
Girschick HJ, Lipsky PE (2002): The human neonatal Kappa Repertoire. Molec Immunol 38:1113-1127
Girschick HJ, Petrasch K, Kühl J (2002): CD-ROM Atlas of Pediatric Hematology, 3. Aufl. Eigenverlag Würzburg.
Girschick HJ (2002): Rheuma bei Kindern – Falsche Enzymaktivität in B-Zellen? BioTec Aktuell 7-8, p 10
Girschick HJ (2002): Erkrankungen des rheumatischen Formenkreises. In: Hebestreit H, Ferrari R, Meyer-Holz J, Lawrenz W, Jüngst BK (Hsg): Kinder- und Jugendsportmedizin: Grundlagen, Praxis, Trainingstherapie, Thieme Verlag Stuttgart, 153-161
Schäd SG, Hamm H, Girschick HJ (2002): Blasen, Erosionen und Narben im Gesicht bei 2 Mädchen mit idiopathischer Arthritis. Hautarzt 53:51-53
Yavuz AS, Monson NL, Yavuz S, Grammer AC, Longo N, Girschick HJ, Lipsky PE (2002): Different patterns of bcl-6 and p53 gene mutations in tonsillar B cells indicate separate mutational mechanisms. Mol Immunol 39:485-93
2001
Nanan R., Peters K., Schrod L., Kreth H.W. (2001) Lethal pneumococcal infection in an 18-month-old girl with splenic hypoplasia and dysgammaglobulinemia. Ann. Hematol. 80:674 - 676;
Neumeister C., Nanan R., Cornu T., Luder T., ter Meulen V., Naim H., Niewiesk S. (2001) Measles virus and canine distemper virus target proteins into a TAP-independent MHC class I-restricted antigen-processing pathway. J. Gen. Virol. 82:441 - 447;
Rösen-Wolff A., Kreth H.W., Hoffmann S., Hoehne K., Heubner G., Möbius D., Zintl F., Roesler M. (2001) Periodic fever (TRAPS) caused by mutations in the TNFa receptor 1 (TNFRSF1A) gene in three German patients. Eur. J. Hematol. 67:105 - 109;
Schuster V., P. Zeitler, S. Seregard, U. Ozcelik, D. Anadol. L. Luchtman-Jones, F. Meire, A.-M. Mingers, Chr. Schambeck, H.W. Kreth (2001) Homozygous and compound-heterozygous type 1 plasminogen deficiency is a common cause of ligneous conjunctivitis. Thromb. Haemost. 85:1004 - 1010;
Weig M., Müller F.M.C., (2001) Synergism of voriconazole and terbinafine against clinical isolates of Candida albicans form HIV-infected patients suffering from oropharyngeal candidiasis. Antimicrob. Chemother. 45:966-968;
Müller F.M.C., Kurzai O., Hacker J., Frosch M., Mühlschlegel F. (2001) Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical Candida dubliensis isolates. J. Antimicrob. Chemother. 48:713-715;
Orimo H, Girschick HJ, Goseki-Zone M, Ito M, Oda K, Shimada T (2001): Mutational analysis and functional correlation with phenotype in german patients with childhood type hypophosphatasia. J Bone Mineral Res 16: 2313-2319
Girschick HJ, Lipsky PE (2001): The human neonatal kappa repertoire. Molec Immunol 38:1113-1127
Girschick HJ, Grammer AC, Nanki T, Mayo M, Lipsky PE (2001): RAG1 and RAG2 expression in human tonsil and peripheral blood B cells. J Immunol 166:377-386
2000
Schuster V., G. Ott, S. Seidenspinner, H.W. Kreth (2000) Limited sequence heterogeneity of Epstein-Barr Virus nuclear antigen 1 in benign and malignant EBV-associated disorders. Infektion 28:137 - 142;
Nanan R., A. Rauch, E. Kämpgen, S. Niewiesk, H.W. Kreth (2000) A noval sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J. Gen. Virol. 81:1313 - 1319;
Schuster V., H.W. Kreth (2000) X-linked lymphoproliferative disease is caused by deficiency of a noval SH2 domain-containing signal transduction adaptor protein. Immunol. Rev. 178:21 - 28;
Ruhnke M., Adler A., Müller F.M. (2000) Clearance of a fluconazole-resistant Candida albicans strain after switsching antifungal therapy and initiation of triple therapy for HIV infection. Clin. Microbiol. Infect. 6:220-223;
Müller F.M.C., Weig M., Peter J., Walsh T.J. (2000) Azole cross-resistence to ketoconazole, fluconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidiasis. J. Antimicrob. Chemother. 46:338-340;
Hayashida K, Nanki T, Girschick HJ, Yavuz S, Lipsky PE (2000): Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthr Res 3:118-126
Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ, Yavuz S, Lipsky PE (2000): Stromal cell-derived Factor -1 - CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. Journal of Immunology 165:6590-6598
1999
Schuster V., H.W. Kreth, X-linked lymphoproliferative disease. In: Primary Immunodeficiency Diseases, A Molecular and Genetic Approach, H.D. Ochs, C.I.E. Smith, J.M. Puck (eds); Oxford University Press, 1999, p. 222 - 232;
Roesler, J., S. Heyden, M. Burdelski, H.J. Schäfer, H.W. Kreth, R. Lehmann, D. Paul, J. Mahrzahn, M. Gahr and A. Rösen-Wolff (1999). Uncommon missense and splice mutations and resulting biochemical phenotypes in German patients with X-linked chronic granulomatous disease. Experimental Haematology 27:505 - 511;
Mingers, A.-M., Philapitsch, P. Zeitler, V. Schuster, H. P. Schwarz, H. W. Kreth (1999) Human homozygous type I plasminogen deficiency and ligneous conjunctivitis. Acta Pathol. Microbiol. Immunol. Scandinavica 107:62 - 72;
Schuster V., S. Seidenspinner, P. Zeitler, C. Escher, U. Pleyer, W. Bernauer, E.R. Stiehm, S. Isenberg, S. Seregard, Th. Olsson, A.-M. Mingers, Chr. Schambeck and H.W. Kreth (1999) Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis. Blood 93:3457 - 3466;
Nanan R., B. Chittka, M. Hadam, H.W. Kreth (1999) Measles virus infection causes transient depletion of activated T cells from peripheral circulation. J. Clin. Virol. 12:201 - 210;
Ströbel Ph., R. Nanan, S. Gattenlöhner, S. Müller-Deubert, H.K.Müller-Hermelink, H.W. Kreth, A. Marx (1999) Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome (ALPS) with functional FAS (CD95/APO-1) deficiency. Am. J. Surg. Pathol. 23:829 - 837;
Zeitler P., N. Meissner, H.W. Kreth (1999) Combination of von Willebrand Disease Typ I and a partial factor XII deficiency in children: Clinical evidence for a diminished bleeding tendency. Acta Paediatrica 88:1233 - 1237;
Nanan, R., H.W. Kreth, 1999 Hindernisse bei der Durchsetzung der Masernimpfung. Kinderärztl. Prax. Sonderheft 2:33 - 35;
Müller F.M.C., Groll A.H. Walsh T.J. (1999) Current approaches in diagnosis and treatment of fungal infections in HIV-infected children. Eur. J. Pediatr. 158:187-199;
Müller F.M.C., Kasai M., Francesconi A., Brillante B., Roden M., Peter J., Chanock S.J., Walsh T.J. (1999) Transmission of an azole-resistant isogenic strain of Candida albicans among HIV-infected family members with oropharyngeal candidiasis. J. Clin. Microbiol. 37(10):3405-3408;
Girschick HJ, Huppertz HI, Harmsen D, Krauspe R, Müller-Hermelink HK, Papadopoulos T (1999): Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum Pathol 30:59-65
Girschick HJ, Meister S, Karch H, Huppertz HI (1999): Borrelia burgdorferi downregulates ICAM-1 on synovial cells in vitro. Cell Adhesion Communic 7:73-83
Girschick HJ, Seyberth HW, Huppertz HI (1999): Treatment of childhood hypophosphatasia with non-steroidal antiinflammatory drugs. Bone 25: 603-607
Girschick HJ, Schneider P, Kruse K, Huppertz HI (1999): Bone metabolism and bone mineral density in childhood hypophosphatasia. Bone 25:361-367
